OpenAI launches GPT‑Rosalind

Biology research runs on huge piles of papers, datasets, and lab tools, and OpenAI has launched a model built to work inside that workflow. (openai.com) OpenAI announced GPT‑Rosalind on April 16, 2026, and said the model is designed for biology, drug discovery, and translational medicine rather than general chat. Reuters reported the company introduced it Thursday as part of a deeper push into life sciences. (openai.com) (reuters.com) In plain terms, the model is meant to help scientists read literature, query databases, compare evidence, and plan experiments in one system. OpenAI said researchers can use it to synthesize evidence, generate hypotheses, and work through multi-step research tasks. (openai.com) (help.openai.com) OpenAI tied the pitch to the long timeline of drug development, saying it often takes about 10 to 15 years to move from target discovery to regulatory approval in the United States. The company said gains at the earliest stages can improve target selection, biological hypotheses, and experiment quality later on. (openai.com) The release also shows how AI companies are carving up work by profession instead of selling one model for every task. Reuters noted OpenAI introduced GPT‑5.4‑Cyber earlier this week for defensive cybersecurity work, while GPT‑Rosalind is aimed at life-sciences research. (reuters.com) OpenAI said GPT‑Rosalind is available as a research preview in ChatGPT, Codex, and the application programming interface, or API, for qualified customers in its trusted access program. It is also launching a free Life Sciences research plugin for Codex that connects to more than 50 scientific tools and data sources. (openai.com) (reuters.com) The product is not a broad public release. OpenAI’s help documentation says it is currently limited to eligible U.S. enterprise customers with legitimate biology research use cases and that individual researchers are not supported. (help.openai.com) OpenAI said the model is most useful for early discovery work such as target biology, mechanism understanding, literature synthesis, and omics interpretation, a term for analyzing large-scale biological data like genes or proteins at once. The company said it is already working with Amgen, Moderna, the Allen Institute, and Thermo Fisher Scientific on research workflows. (help.openai.com) (openai.com) The model is named after Rosalind Franklin, the British scientist whose work helped reveal DNA’s structure. For now, OpenAI is framing GPT‑Rosalind as a research tool for early-stage science, not a consumer chatbot for health advice. (reuters.com) (openai.com)